NVTA - NVTA インビティ ()

NVTAのニュース

   Invitae launches genetic tests for children with neurodevelopmental disorders  2022/04/04 14:26:19 Seeking Alpha
Invitae (NVTA) announced the commercial launch of its Neurodevelopmental Disorders ((NDD)) testing package for children with developmental disabilities. The company said the…
   2 Charts That Explain Invitae''s Shortcomings  2022/03/30 12:05:00 The Motley Fool
Invitae is a leading genetic testing company that''s been public since 2015. Why has the stock done so poorly?
   Golden Stock: TherapeuticsMD, Inc. (NASDAQ:TXMD), Invitae Corporation (NYSE:NVTA)  2022/03/23 00:34:35 Stock Equity
TherapeuticsMD, Inc. (NASDAQ:TXMD) with the stream of 1.21% also noticed, India Invitae Corporation (NYSE:NVTA) encountered a rapid change of 7.66% in the last hour of Tuesday’s trading session. TherapeuticsMD, Inc. … The post Golden Stock: TherapeuticsMD, Inc. (NASDAQ:TXMD), Invitae Corporation (NYSE:NVTA) appeared first on Stocks Equity .
   Why Invitae Stock Rose 10.7% on Tuesday  2022/03/22 19:50:50 The Motley Fool
The molecular diagnostics company is bouncing back from its two-year low.
   Invitae Corporation (NYSE: NVTA) Is Rated A Buy By Analysts.  2022/03/21 18:30:00 Marketing Sentinel
In the latest trading session, 2.25 million Invitae Corporation (NYSE:NVTA) shares changed hands as the company’s beta touched 1.82. With the company’s most recent per share price at $8.22 changed hands at -$0.16 or -1.91% at last look, the market valuation stands at $1.85B. NVTA’s current price is a discount, trading about -432.24% off its … Invitae Corporation (NYSE: NVTA) Is Rated A Buy By Analysts. Read More »
   Invitae launches genetic tests for children with neurodevelopmental disorders  2022/04/04 14:26:19 Seeking Alpha
Invitae (NVTA) announced the commercial launch of its Neurodevelopmental Disorders ((NDD)) testing package for children with developmental disabilities. The company said the…
   2 Charts That Explain Invitae''s Shortcomings  2022/03/30 12:05:00 The Motley Fool
Invitae is a leading genetic testing company that''s been public since 2015. Why has the stock done so poorly?
   Golden Stock: TherapeuticsMD, Inc. (NASDAQ:TXMD), Invitae Corporation (NYSE:NVTA)  2022/03/23 00:34:35 Stock Equity
TherapeuticsMD, Inc. (NASDAQ:TXMD) with the stream of 1.21% also noticed, India Invitae Corporation (NYSE:NVTA) encountered a rapid change of 7.66% in the last hour of Tuesday’s trading session. TherapeuticsMD, Inc. … The post Golden Stock: TherapeuticsMD, Inc. (NASDAQ:TXMD), Invitae Corporation (NYSE:NVTA) appeared first on Stocks Equity .
   Why Invitae Stock Rose 10.7% on Tuesday  2022/03/22 19:50:50 The Motley Fool
The molecular diagnostics company is bouncing back from its two-year low.
   Invitae Corporation (NYSE: NVTA) Is Rated A Buy By Analysts.  2022/03/21 18:30:00 Marketing Sentinel
In the latest trading session, 2.25 million Invitae Corporation (NYSE:NVTA) shares changed hands as the company’s beta touched 1.82. With the company’s most recent per share price at $8.22 changed hands at -$0.16 or -1.91% at last look, the market valuation stands at $1.85B. NVTA’s current price is a discount, trading about -432.24% off its … Invitae Corporation (NYSE: NVTA) Is Rated A Buy By Analysts. Read More »
   Dimensional Fund Advisors LP Has $1.13 Million Stock Position in Invitae Co. (NYSE:NVTA)  2021/11/08 09:34:45 Dakota Financial News
Dimensional Fund Advisors LP decreased its position in shares of Invitae Co. (NYSE:NVTA) by 77.2% in the second quarter, Holdings Channel.com reports. The firm owned 33,408 shares of the medical research companys stock after selling 113,396 shares during the period. Dimensional Fund Advisors LPs holdings in Invitae were worth $1,127,000 as of its most recent []
   Zacks: Analysts Anticipate Invitae Co. (NYSE:NVTA) Will Announce Quarterly Sales of $125.29 Million  2021/11/08 03:14:41 Transcript Daily
Wall Street analysts expect that Invitae Co. (NYSE:NVTA) will report sales of $125.29 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Invitaes earnings, with the highest sales estimate coming in at $130.97 million and the lowest estimate coming in at $123.00 million. Invitae reported sales of []
   Invitae Q3 2021 Earnings Preview  2021/11/07 21:35:00 Seeking Alpha
   Adalta Capital Management LLC Takes $209,000 Position in Invitae Co. (NYSE:NVTA)  2021/11/07 17:24:42 Transcript Daily
Adalta Capital Management LLC bought a new stake in Invitae Co. (NYSE:NVTA) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,210 shares of the medical research companys stock, valued at approximately $209,000. Other large investors have also recently bought and []
   California State Teachers Retirement System Acquires 93,223 Shares of Invitae Co. (NYSE:NVTA)  2021/11/07 12:48:42 Transcript Daily
California State Teachers Retirement System boosted its holdings in shares of Invitae Co. (NYSE:NVTA) by 51.0% during the second quarter, HoldingsChannel reports. The fund owned 276,130 shares of the medical research companys stock after purchasing an additional 93,223 shares during the quarter. California State Teachers Retirement Systems holdings in Invitae were worth $9,314,000 at the []

calendar